Health

Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China

NANJING, China and SEOUL, South Korea, Sept. 27, 2019 /PRNewswire/ -- Simcere Pharmaceutical Group and JW Pharmaceutical (KRX:001060, hereinafter called "JWP") announced a collaboration and exclusive license agreement for anti-gout drug candidate URC-102 inChina (including Chinese Hongkong & Maca...

2019-09-27 18:52 5085

Bactiguard Signs Global License Agreement With Zimmer Biomet

STOCKHOLM, Sept. 27, 2019 /PRNewswire/ -- Bactiguard has entered into an exclusive, global license agreement for orthopedic trauma implants with Zimmer Biomet. The agreement includes an upfront license fee ofUSD 3 million payable at signing, additional contingent payments ofUSD 2 million, based o...

2019-09-27 14:16 1727

New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019

Not intended for US, Canada and UK-based media  DARMSTADT, Germany, and NEW YORK, Sept. 27, 2019 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced the presentation of multiple analyses from the JAVELIN clinical development program assessing BAVENCIO® (avelumab) alone or as part o...

2019-09-27 14:00 2292

TUV Rheinland: Notified Body for the New Medical Device Regulation

COLOGNE, Germany, Sept. 27, 2019 /PRNewswire/ -- TUV Rheinland LGA Products GmbH is now a notified body for the EU Medical Device Regulation (MDR) 2017/745. The European Medical Device Regulation 2017/745 (MDR) came into effect on May 25, 2017, and will replace Directive 93/42/EEC (MDD) and Dire...

2019-09-27 11:00 1810

AIT Worldwide Logistics' Life Sciences Control Tower earns Good Distribution Practices certification

GDP certification reinforces global logistics leader's high quality, security, cold-chain standards ITASCA, Illinois, Sept. 27, 2019 /PRNewswire/ -- AIT Worldwide Logistics' life sciences division recently received Good Distribution Practice (GDP) certification for its central hub inItasca, Ill....

2019-09-27 02:02 2525

Fangchenggang International Medical Opening-up Pilot Zone Strategic Dialogue Conference was held in Nanning, Guangxi

NANNING, China, Sept. 26, 2019 /PRNewswire/ -- As reported by CRI Online: On September 23, the Fangchenggang International Medical Opening-up Pilot Zone ( China) Strategic Dialogue Conference was held in Nanning, China. More than 260 people were invited, including experts in international research...

2019-09-26 23:15 3418

CYZone announced "The 2019 Top 50 Healthcare Innovation Enterprises" in China

HANGZHOU, China, Sept. 26, 2019 /PRNewswire/ -- CYZone (www.cyzone.cn ), a leading innovation service platform in China, recently announced "The 2019 Top 50 Healthcare Innovation Enterprises inChina" on Demo China FutureTech Festival. There are 50 prominent companies on th...

2019-09-26 21:36 1231

New Clarivate Analytics report shows the cost to bring a drug to market has decreased to under $2B for the first time in over five years

Pharmaceutical R&D industry report provides insights into what's behind decade-high drug approval rates and reveals implications of costs and sustainability LONDON and PHILADELPHIA, Sept. 26, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC; CCC.WS), a global leader in providing trusted in...

2019-09-26 21:00 6649

Medtec China 2019 Inaugurated in Shanghai on September 25

SHANGHAI, Sept. 26, 2019 /PRNewswire/ -- Medtec China 2019, organized by Informa Markets, was inaugurated onSeptember 25 in Shanghai. It brings together more than 450 high-quality brands, and is expected to receive 25,000 professional visitors over its three days. The opening ceremony of Medtec C...

2019-09-26 20:57 4370

Thermo Fisher Scientific Expands Clinical Trials Capabilities and Announces Collaboration with Frontier Biotechnologies Inc.

SUZHOU, China, Sept. 26, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, announced today an expansion of its integrated clinical trials supply and distribution services network, in Suzhou,China, as well as a collaboration with Frontier Biotechnologies Inc. to d...

2019-09-26 14:00 3789

The Initiators of the China-Italy Forum Opined on Poverty Alleviation at the China Charity Fair

SHENZHEN, China, Sept. 26, 2019 /PRNewswire/ -- On September 20, 2019, the 2019 International Charity Summit on the theme of "Great Power Battle in 2020" was held inShenzhen. Focused on the core issues, weak points and key chains of the current poverty battle, and the hot and difficult issues in ...

2019-09-26 11:01 1683

Herbalife Nutrition Launches "Nutrition for Zero Hunger" Initiative, Pledging US$2M to Help Fight Global Hunger

HONG KONG, Sept. 26, 2019 /PRNewswire/ -- Herbalife Nutrition (NYSE:HLF), a premier global nutrition company, today announced the launch of theNutrition for Zero Hunger global initiative, pledging US$2 million to help end world hunger, ensure people have access to good nutrition and address risin...

2019-09-26 11:00 8311

FIBO to be held in Southeast Asia from 2020

SINGAPORE, Sept. 26, 2019 /PRNewswire/ -- Next year will see the first FIBO Southeast Asia (FIBO SEA) kicks off. From 24 to26 September 2020, it will bring together brands, manufacturers, distributors, licensors, intermediaries, buyers and trainers from theSoutheast Asia and international fitness...

2019-09-26 08:15 2926

OrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent

HONG KONG, Sept. 26, 2019 /PRNewswire/ -- OrbusNeich Medical K.K. of Tokyo Japan has announced that the Japan Ministry of Health, Labour, and Welfare (MHLW) has granted Shonin market approval for the COMBO Plus Coronary Stent.  The COMBO Plus Coronary Stent is the first drug-eluting stent [DES] t...

2019-09-26 01:01 1719

Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications

HANGZHOU, China, Sept. 25, 2019 /PRNewswire/ -- The preclinical results of AB-106 (original code: DS-6051b), an investigational next generation ROS1/NTRK dual inhibitor exclusively in-licensed by AnHeart Therapeutics, a wholly-owned subsidiary of Baoyuan Biopharmaceuticals Technology (Hangzhou) C...

2019-09-25 18:44 4250

Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications

HANGZHOU, China, Sept. 25, 2019 /PRNewswire/ -- The preclinical results of AB-106 (original code: DS-6051b), an investigational next generation ROS1/NTRK dual inhibitor exclusively in-licensed by AnHeart Therapeutics, a wholly-owned subsidiary of Baoyuan Biopharmaceuticals Technology (Hangzhou) C...

2019-09-25 18:35 2442

Launch of the Penlon Sigma EVA Vaporizer for Desflurane

ABINGDON, England, Sept. 25, 2019 /PRNewswire/ -- Penlon Ltd, UK-based manufacturer of Anaesthesia equipment, is proud to announce the launch of the new Sigma EVA, an advanced electronic vaporizer specifically designed to provide a better way to deliver of Desflurane. Penlon will be one of a very...

2019-09-25 17:00 2682

The Royal College of Surgeons of Edinburgh Launched a New International Strategy to Support Surgeons and Dentists Around the Globe

KUALA LUMPUR, Malaysia, Sept. 25, 2019 /PRNewswire/ -- The Royal College of Edinburgh, one of the oldest such Colleges in the World, today launched its International Strategy to support Surgeons and Dentists worldwide, through education, training and examinations and to advocate for the Highest S...

2019-09-25 13:00 1282

Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA's approval of the oral formulation of Akynzeo(R) in China

LUGANO, Switzerland and BEIJING, Sept. 25, 2019 /PRNewswire/ -- Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Mundipharma China Pharmaceutical, the market leader in pain management, today jointly announce that the National Medical Products Administrat...

2019-09-25 12:11 3695

The CareVoice officially launches CareVoiceOS(TM)

BEIJING, Sept. 25, 2019 /PRNewswire/ -- The CareVoice, an international health insurtech company based inChina, who recently closed an eight-figure USD Series A funding round, announced today the launch of CareVoiceOS(TM), its latest product innovation that will be available in mainlandChina and ...

2019-09-25 09:56 3169